C. Meares

发表

Selectivity of antibody-chelate conjugates for binding copper in the presence of competing metals

D. Kukis, Min Li, C. Meares, 1993 .

A novel method to label preformed liposomes with 64Cu for positron emission tomography (PET) imaging.

Katherine W Ferrara, J. Seo, K. Ferrara, 2008, Bioconjugate chemistry.

Mapping the σ70 subunit contact sites on Escherichia coli RNA polymerase with a σ70-conjugated chemical protease

Akira Ishihama, K. Murakami, N. Fujita, 1998 .

Positioning of two alpha subunit carboxy-terminal domains of RNA polymerase at promoters by two transcription factors.

K. Murakami, S. Busby, A. Ishihama, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Biodistribution and dosimetry of pretargeted monoclonal antibody 2D12.5 and Y-Janus-DOTA in BALB/c mice with KHJJ mouse adenocarcinoma.

C. Meares, M. Hays, S. P. Lubic, 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Study of biological macromolecules by diffusion-enhanced lanthanide energy transfer

T. Wensel, C. Meares, 1989 .

Copper chelates as probes of biological systems: stable copper complexes with a macrocyclic bifunctional chelating agent.

S. Denardo, C. Meares, M. Mccall, 1985, Analytical biochemistry.

A comparative study of copper‐67 radiolabeling and kinetic stabilities of antibody‐macrocycle chelate conjugates

G. Denardo, S. Denardo, D. Kukis, 1994, Cancer.

Effect of the extent of chelate substitution on the immunoreactivity and biodistribution of 2IT-BAT-Lym-1 immunoconjugates.

G. Denardo, S. Denardo, L. Miers, 1995, Cancer research.

Antibody responses to macrocycles in lymphoma.

G. Denardo, S. Denardo, C. Meares, 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Maximum tolerated dose of 67Cu-2IT-BAT-LYM-1 for fractionated radioimmunotherapy of non-Hodgkin's lymphoma: a pilot study.

G. Denardo, S. Denardo, S. Shen, 1998, Anticancer research.

Zinc is associated with the beta subunit of DNA-dependent RNA polymerase of Bacillus subtilis.

S. Halling, C. Meares, R. Doi, 1977, Biochemistry.

Binding of the sigma 70 protein to the core subunits of Escherichia coli RNA polymerase, studied by iron-EDTA protein footprinting.

A. Gunasekera, C. Meares, D. P. Greiner, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Effect of Molecular Shape and Flexibility on Gamma‐Ray Directional Correlations

C. Meares, A. Marshall, L. Werbelow, 1972 .

Cobalt-bleomycins and deoxyribonucleic acid: sequence-dependent interactions, action spectrum for nicking, and indifference to oxygen.

C. Chang, C. Meares, 1984, Biochemistry.

Photosensitization of cobalt bleomycin

C. Meares, R. Subramanian, 1986 .

Photoinduced DNA strand scission by cobalt bleomycin green complex

H. Sugiyama, S. Hecht, C. Meares, 1989 .

Asbestos fibers in the colonic wall.

A. Maraveyas, C. Meares, D. Snook, 1974, British Journal of Cancer.

The peptide way to macrocyclic bifunctional chelating agents: synthesis of 2-(p-nitrobenzyl)-1,4,7,10-tetraazacyclododecane-N,N',N",N'''-tetraacetic acid and study of its yttrium(III) complex.

S. Denardo, C. Meares, M. Moi, 1988, Journal of the American Chemical Society.

Simplified method for conjugating macrocyclic bifunctional chelating agents to antibodies via 2-iminothiolane.

C. Meares, M. Mccall, H. Diril, 1990, Bioconjugate chemistry.

Synthesis, metal chelate stability studies, and enzyme digestion of a peptide-linked DOTA derivative and its corresponding radiolabeled immunoconjugates.

Min Li, C. Meares, M. Li, 1993, Bioconjugate chemistry.

Labeling monoclonal antibodies with 90yttrium- and 111indium-DOTA chelates: a simple and efficient method.

S. Denardo, L. Miers, C. Meares, 1994, Bioconjugate chemistry.

Prelabeling of chimeric monoclonal antibody L6 with 90yttrium- and 111indium-1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid (DOTA) chelates for radioimmunodiagnosis and therapy.

S. Denardo, L. Miers, D. Kukis, 1995, Cancer research.

Yttrium-90/indium-111-DOTA-peptide-chimeric L6: pharmacokinetics, dosimetry and initial results in patients with incurable breast cancer.

G. Denardo, S. Denardo, S. Shen, 1997, Anticancer research.

Cathepsin substrates as cleavable peptide linkers in bioconjugates, selected from a fluorescence quench combinatorial library.

C. Meares, J. Peterson, 1998, Bioconjugate chemistry.

Enzymatic cleavage of peptide-linked radiolabels from immunoconjugates.

C. Meares, J. Peterson, 1999, Bioconjugate chemistry.

Radiation dosimetry for 90Y-2IT-BAD-Lym-1 extrapolated from pharmacokinetics using 111In-2IT-BAD-Lym-1 in patients with non-Hodgkin's lymphoma.

G. Denardo, S. Denardo, S. Shen, 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Conjugation of antibodies with metal chelates

C. Meares, 1989 .

Element-coded affinity tags for peptides and proteins.

C. Meares, P. Whetstone, N. Butlin, 2004, Bioconjugate chemistry.

Yttrium-90-DOTA-peptide-chimeric L6 radioimmunoconjugate: efficacy and toxicity in mice bearing p53 mutant human breast cancer xenografts.

K. Lamborn, G. Denardo, S. Denardo, 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Imaging cancer using PET--the effect of the bifunctional chelator on the biodistribution of a (64)Cu-labeled antibody.

S. Treves, J. Huston, C. Meares, 2011, Nuclear medicine and biology.

Development of humoral immune responses against a macrocyclic chelating agent (DOTA) in cancer patients receiving radioimmunoconjugates for imaging and therapy.

C. Meares, M. Mccall, C. Gooden, 1992, Cancer research.

Tumour localisation with a radioactively labelled reshaped human monoclonal antibody.

A. Bamias, C. Meares, R. A. Badley, 1991, British Journal of Cancer.

Optimized conditions for chelation of yttrium-90-DOTA immunoconjugates.

G. Denardo, S. Denardo, D. Kukis, 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Comparative toxicity studies of yttrium‐90 mx‐dtpa and 2‐it‐bad conjugated monoclonal antibody (bre‐3)

G. Denardo, S. Denardo, S. Shen, 1994, Cancer.

Synthesis of mono- and dinucleotide photoaffinity probes of ribonucleic acid polymerase.

C. Meares, L. Deriemer, L. DeRiemer, 1981, Biochemistry.

Critical Lym-1 binding residues on polymorphic HLA-DR molecules.

K. Lamborn, G. Denardo, C. Meares, 1999, Molecular immunology.

67Cu-versus 131I-labeled Lym-1 antibody: comparative pharmacokinetics and dosimetry in patients with non-Hodgkin's lymphoma.

G. Denardo, S. Denardo, S. Shen, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Radioimmunotherapy after chemotherapy compared to chemotherapy alone in the treatment of advanced ovarian cancer: a matched analysis.

A. Maraveyas, C. Meares, C. Gooden, 1998, Oncology reports.

Pharmacokinetics of chimeric L6 conjugated to indium-111- and yttrium-90-DOTA-peptide in tumor-bearing mice.

G. Denardo, S. Denardo, C. Meares, 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Converting weak binders into infinite binders.

C. Meares, P. Whetstone, T. M. Corneillie, 2004, Bioconjugate chemistry.

Pre-targeted immunoscintigraphy of murine tumors with indium-111-labeled bifunctional haptens.

C. Meares, M. Mccall, D. Goodwin, 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Influence of a peptide linker on biodistribution and metabolism of antibody-conjugated benzyl-EDTA. Comparison of enzymatic digestion in vitro and in vivo.

S. Denardo, D. Kukis, C. Meares, 1992, Bioconjugate chemistry.

67 Cu- versus 131 I-Labeled Lym-1 Antibody: Comparative Pharmacokinetics and Dosimetry in Patients with Non-Hodgkin’s Lymphoma 1

G. Denardo, S. Denardo, S. Shen, 1999 .

Strategies for enhancement of radioimmunotherapy.

G. Denardo, S. Denardo, D. Kukis, 1991, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

Rapid PCR construction of a gene containing Lym-1 antibody variable regions.

G. Denardo, S. Denardo, P. Gumerlock, 1993, PCR methods and applications.

Use of specific antibody for rapid clearance of circulating blood background from radiolabeled tumor imaging proteins

F. Torti, C. Meares, M. Mccall, 2004, European Journal of Nuclear Medicine.

Covalent attachment of metal chelates to proteins:the stability in vivo and in vitro of the conjugate of albumin with a chelate of 111indium.

A. Nunn, C. Meares, D. Silvester, 1976, Proceedings of the National Academy of Sciences of the United States of America.

Advances in pretargeting biotechnology.

C. Meares, D. Goodwin, D. A. Goodwin, 2001, Biotechnology advances.

Pretargeted peptide imaging and therapy.

C. Meares, D. Goodwin, 1999, Cancer biotherapy & radiopharmaceuticals.

Pretargeting: Improved Pharmacokinetics and Therapeutic Ratio

C. Meares, D. Goodwin, M. McTigue, 1997 .

Preparation, biodistribution and dosimetry of copper-64-labeled anti-colorectal carcinoma monoclonal antibody fragments 1A3-F(ab')2.

P. Cutler, C. Meares, K. Zinn, 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

New anti-Cu-TETA and anti-Y-DOTA monoclonal antibodies for potential use in the pre-targeted delivery of radiopharmaceuticals to tumor.

G. Denardo, S. Denardo, C. Meares, 1998, Hybridoma.

Macrocyclic chelates of radiometals for diagnosis and therapy.

S. Denardo, D. Kukis, C. Meares, 1990, The British journal of cancer. Supplement.

Antibody with Infinite Affinity for In Vivo Tracking of Genetically Engineered Lymphocytes

S. Larson, T. Reiner, M. Sadelain, 2018, The Journal of Nuclear Medicine.

Pharmacokinetics of pretargeted monoclonal antibody 2D12.5 and 88Y-Janus-2-(p-nitrobenzyl)-1,4,7,10-tetraazacyclododecanetetraacetic acid (DOTA) in BALB/c mice with KHJJ mouse adenocarcinoma: a model for 90Y radioimmunotherapy.

D. Kukis, C. Meares, N. Watanabe, 1994, Cancer research.

A rare earth-DOTA-binding antibody: probe properties and binding affinity across the lanthanide series.

A. Fisher, C. Meares, P. Whetstone, 2003, Journal of the American Chemical Society.

67Cu-2IT-BAT-Lym-1 pharmacokinetics, radiation dosimetry, toxicity and tumor regression in patients with lymphoma.

G. Denardo, S. Denardo, S. Shen, 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Transfer of copper from a chelated 67Cu-antibody conjugate to ceruloplasmin in lymphoma patients.

G. Denardo, S. Denardo, S. Shen, 1999, Nuclear medicine and biology.

acid (DOTA)-.Peptide-ChL6, a Novel linmunoconjugate with Catabolizable Linker, to 2-Iminothiolane-2- (p-(Bromoacetamido)benzyl)-DOTA-ChL6 in Breast Cancer Xenografts'

K. Lamborn, G. Denardo, S. Denardo, 1998 .

Engineered Antibody Fragments with Infinite Affinity as Reporter Genes for PET Imaging

Mark R. McCoy, M. Phelps, J. Czernin, 2008, Journal of Nuclear Medicine.

Metabolizable 111in chelate conjugated anti-idiotype monoclonal antibody for radioimmunodetection of lymphoma in mice

M. Kaminski, T. Wensel, C. Meares, 1986, European Journal of Nuclear Medicine.

Chelate conjugates of monoclonal antibodies for imaging lymphoid structures in the mouse.

C. Meares, M. Mccall, D. Goodwin, 1985, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Immunogenicity in rabbits and mice of an antibody-chelate conjugate: comparison of (S) and (R) macrocyclic enantiomers and an acyclic chelating agent.

C. Meares, D. Goodwin, M. McTigue, 1994, Cancer research.

Chelating agents for the binding of metal ions to antibodies.

C. Meares, 1986, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

Cysteinylated protein as reactive disulfide: an alternative route to affinity labeling.

Mark R. McCoy, C. Meares, S. Cheal, 2008, Bioconjugate chemistry.

Copper-67-labeled monoclonal antibody Lym-1, a potential radiopharmaceutical for cancer therapy: labeling and biodistribution in RAJI tumored mice.

G. Denardo, S. Denardo, G. Adams, 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Pretargeted Immunoscintigraphy: Effectof HaptenValencyon MurineTumorUptake

C. Meares, M. Mccall, D. Goodwin, 1992 .

Monoclonal antibodies as reversible equilibrium carriers of radiopharmaceuticals.

C. Meares, M. Mccall, M. Stone, 1986, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

Physiological barriers to chelate-tagged monoclonals?

C. Meares, 1987 .

Linking radiometals to proteins with bifunctional chelating agents

C. Meares, D. Goodwin, 1984 .

Antibodies with infinite affinity: origins and applications.

C. Meares, N. Butlin, 2006, Accounts of chemical research.

Chelate radiochemistry: Cleavable linkers lead to altered levels of radioactivity in the liver

S. Denardo, C. Meares, M. Mccall, 1988, International journal of cancer. Supplement = Journal international du cancer. Supplement.

Effect of mass of 111In-benzyl-EDTA monoclonal antibody on hepatic uptake and processing in mice.

G. Denardo, S. Denardo, G. Adams, 1989, Cancer research.

The Design of a Radiolabeled Monoclonal Antibody for Radioimmunodiagnosis and Radioimmunotherapy

G. Denardo, S. Denardo, G. Adams, 1988 .

The attachment of metal-chelating groups to protein: tagging of albumin by diazonium coupling and use of the products as radiopharmaceuticals.

C. Meares, D. Goodwin, C. Leung, 1978, The International journal of applied radiation and isotopes.

Irreversible engineering of the multielement-binding antibody 2D12.5 and its complementary ligands.

C. Meares, P. Whetstone, T. M. Corneillie, 2004, Bioconjugate chemistry.

New covalent capture probes for imaging and therapy, based on a combination of binding affinity and disulfide bond formation.

S. Cherry, G. Mitchell, T. Aweda, 2011, Bioconjugate chemistry.

Chemically modified antibodies as diagnostic imaging agents.

J. J. Day, T. Aweda, C. Meares, 2010, Current opinion in chemical biology.

Biodistribution in tumour‐bearing mice of two 90Y‐labelled biotins using three‐step tumour targeting

F. Fazio, C. Meares, G. Paganelli, 1997, Nuclear medicine communications.

Metabolite production in patients with lymphoma after radiometal-labeled antibody administration.

G. Denardo, S. Denardo, S. Shen, 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Total solid-phase synthesis of 1,4,7,10-tetraazacyclododecane-N,N', N'',N'''-tetraacetic acid-functionalized peptides for radioimmunotherapy.

C. Meares, R. Pak, J. Peterson, 1999, Bioconjugate chemistry.

Comparative serum stability of radiochelates for antibody radiopharmaceuticals.

G. Denardo, S. Denardo, A. Epstein, 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Pharmacokinetics and toxicity of an yttrium‐90‐citc‐dtpa‐hmfg1 radioimmunoconjugate for intraperitoneal radioimmunotherapy of ovarian cancer

A. Maraveyas, C. Meares, A. Epenetos, 1994 .

Pharmacokinetics and toxicity of an yttrium-90-CITC-DTPA-HMFG1 radioimmunoconjugate for intraperitoneal radioimmunotherapy of ovarian cancer.

A. Maraveyas, C. Meares, D. Snook, 1994, Cancer.

Metabolism of indium chelates attached to monoclonal antibody: minimal transchelation of indium from benzyl-EDTA chelate in vivo.

G. Denardo, S. Denardo, C. Meares, 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Improved synthesis of 6-[p-(bromoacetamido)benzyl]-1,4,8,11-tetraazacyclotetradecane- N,N',N",N"-tetraacetic acid and development of a thin-layer assay for thiol-reactive bifunctional chelating agents.

C. Meares, D. P. Greiner, J. Moran, 1995, Bioconjugate chemistry.

Large-scale synthesis of the bifunctional chelating agent 2-(p-nitrobenzyl)-1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetr aacetic acid, and the determination of its enantiomeric purity by chiral chromatography.

C. Meares, O. Renn, 1992, Bioconjugate chemistry.

X-ray crystal structure of a macrocyclic copper chelate stable enough for use in living systems: Copper(II) dihydrogen 6-(p-nitrobenzyl)-1,4,8,11-tetraazacyclotetradecane-1,4,8,11-tetraacetate

S. Denardo, C. Meares, H. Hope, 1987 .

Selective binding of metal ions to macromolecules using bifunctional analogs of EDTA.

C. Meares, D. Goodwin, M. W. Sundberg, 1974, Journal of medicinal chemistry.

Chelating agents for the binding of metal ions to macromolecules

C. Meares, D. Goodwin, M. W. Sundberg, 1974, Nature.

New approaches to delivering metal-labeled antibodies to tumors : Synthesis and characterization of new biotinyl chelate conjugates for pre-targeted diagnosis and therapy

C. Meares, V. Jacques, D. Goodwin, 1996 .

Clinical studies with In-111 BLEDTA, a tumor-imaging conjugate of bleomycin with a bifunctional chelating agent.

D. Sartoris, C. Meares, D. Goodwin, 1981, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Synthesis of novel 1,4,7-triazacyclononane-N,N',N"-triacetic acid derivatives suitable for protein labeling.

C. Meares, M. Studer, 1992, Bioconjugate chemistry.

Metal-Complex-Catalyzed Cleavage of Biopolymers

C. Meares, R. Marusak, 1995 .

Molecular tools for targeted imaging and therapy of cancer

C. Meares, A. Chmura, P. Whetstone, 2003, Journal of molecular recognition : JMR.

Electrophilic chelating agents for irreversible binding of metal chelates to engineered antibodies.

C. Meares, A. Chmura, S. Traviglia, 2002, Journal of controlled release : official journal of the Controlled Release Society.

Pretargeted immunoscintigraphy: effect of hapten valency on murine tumor uptake.

C. Meares, M. Mccall, D. Goodwin, 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Indium-111-labeled autologous platelets for location of vascular thrombi in humans.

M. Lipton, J. Bushberg, P. Doherty, 1978, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

N-terminal modification of immunoglobulin polypeptide chains tagged with isothiocyanato chelates.

T. Rana, C. Meares, 1990, Bioconjugate chemistry.

Enhancing peptide ligand binding to vascular endothelial growth factor by covalent bond formation.

J. J. Day, C. Lebrilla, B. Phinney, 2012, Bioconjugate chemistry.

Bledta II: Synthesis of a new tumor-visualizing derivative of CO(III)-bleomycin

C. Meares, D. Goodwin, C. Diamanti, 1981 .

Photoaffinity labeling of RNA polymerase III transcription complexes by nascent RNA.

C. Meares, B. Bartholomew, M. Dahmus, 1990, The Journal of biological chemistry.

Clinical Studieswith In-i 11 BLEDTA, A Tumor-ImagingConjugateof Bleomycin with a BifunctionalChelatingAgent

D. Sartoris, C. Meares, R. Goode, 2006 .

BIFUNCTIONAL CHELATING AGENTS: LINKING RADIOMETALS TO BIOLOGICAL MOLECULES

C. Meares, D. Goodwin, C. Chang, 1982 .

Decomposition rates of radiopharmaceutical indium chelates in serum

C. Meares, D. Goodwin, S. Yeh, 1979 .

Conjugation of Bifunctional Chelating Agents to Bleomycin for Use in Nuclear Medicine

C. Meares, D. Goodwin, L. Remier, 1979 .

The study of 111 In-labeled compounds in mice, using perturbed angular correlations of gamma radiations.

C. Meares, D. Goodwin, C. Song, 1972, Radiology.

Interaction of oxidized chicken ovotransferrin with chicken embryo red blood cells.

M. Penner, C. Meares, R. Feeney, 1985, Biochimica et biophysica acta.

Biological properties of biotin-chelate conjugates for pretargeted diagnosis and therapy with the avidin/biotin system.

C. Meares, D. Goodwin, M. Osen, 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

PRETARGETED Y-90 THERAPY: PHARMACOKINETICS AND THERAPEUTIC RATIO IN BALB/C MICE WITH KHJJ MOUSE ADENOCARCINOMA USING MAB 2D12.5 AND Y-88 JANUS DOTA

C. Meares, D. Goodwin, M. McTigue, 1993 .

Large‐Scale Synthesis of the Bifunctional Chelating Agent 2‐(p‐ Nitrobenzyl)‐1,4,7,10‐tetraazacyclododecane‐N,N′,N′′,N′′′‐tetraacetic Acid, and the Determination of Its Enantiomeric Purity by Chiral Chromatography.

C. Meares, O. Renn, 1993 .

IMMUNOGENICITY OF (S) AND (R) ENANTIOMERS OF A MACROCYCLIC BIFUNCTIONAL CHELATING AGENT WITH IMMUNOCONJUGATES IN RABBITS

C. Meares, D. Goodwin, M. McTigue, 1992 .

Expression of recombinant Lym‐1 single‐chain Fv in Escherichia coli

C. Meares, M. Won, K. Bin Song, 1998, Biotechnology and applied biochemistry.

The chemistry of irreversible capture.

C. Meares, 2008, Advanced drug delivery reviews.

Light-induced nicking of deoxyribonucleic acid by cobalt(III) bleomycins.

C. Chang, C. Meares, 1982, Biochemistry.

Amphiphilic spectroscopic probes utilizing metal chelates

C. Meares, S. Yeh, 1979, Experientia.

A convenient and flexible approach for introducing linkers on bifunctional chelating agents.

C. Meares, M. Studer, 1992, Bioconjugate chemistry.

Serum stability of 67Cu chelates: comparison with 111In and 57Co.

G. Denardo, S. Denardo, A. Epstein, 1986, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

Indium-111 Labeled Cells: New Approaches and Radiation Dosimetry

C. Meares, D. Goodwin, 1985 .

Technetium-99 m complexes of EDTA analogs: studies of the radiochemistry and biodistribution.

C. Meares, D. Goodwin, R. Baker, 1981, International journal of nuclear medicine and biology.

Attachment of fluorescent metal chelates to macromolecules using "bifunctional" chelating agents.

C. Meares, C. Leung, 1977, Biochemical and biophysical research communications.

Radiolabeled antitumor agents.

C. Meares, D. Goodwin, 1976, Seminars in nuclear medicine.

SELECTIVE BINDING OF METAL IONS TO MACROMOLECULES USING BIFUNCTIONAL ANALOGS OF EDTA

C. Meares, D. Goodwin, M. W. Sundberg, 1975 .

Perturbed angular correlation study of a haptenic molecule.

J. Baldeschwieler, C. Meares, M. W. Sundberg, 1972, Proceedings of the National Academy of Sciences of the United States of America.

Effect of Slow Rotational Diffusion on Angular Correlations

C. Meares, A. Marshall, 1972 .

Effect of different linkages between chelates and monoclonal antibodies on levels of radioactivity in the liver.

G. Denardo, S. Denardo, G. Adams, 1989, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

Combination of isothermal titration calorimetry and time-resolved luminescence for high affinity antibody-ligand interaction thermodynamics and kinetics.

T. Aweda, C. Meares, 2012, Methods.

Effect of Mass of ' "In-Benzyl-EDTA Monoclonal Antibody on Hepatic Uptake and Processing in Mice1

Shrikant, G. Denardo, S. Denardo, 2006 .

Radiopharmaceutical preparation of a monoclonal antibody, lym‐1, and its F(ab')2 fragment for imaging lymphoma with In‐111

G. Denardo, S. Denardo, A. Epstein, 1989 .

Photo-induced nicking of deoxyribonucleic acid by ruthenium(II)-bleomycin in the presence of air.

C. Meares, R. Subramanian, 1985, Biochemical and biophysical research communications.

Yttrium-90-labeled monoclonal antibody for therapy: labeling by a new macrocyclic bifunctional chelating agent.

G. Denardo, S. Denardo, D. Kukis, 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

In vivo comparison of copper blood-pool agents: potential radiopharmaceuticals for use with copper-62.

M. Welch, S. Bergmann, C. Meares, 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Chelates for Radioimmunodiagnosis and Therapy'

S. Denardo, L. Miers, D. Kukis, 2006 .

Pharmacokinetics of Chimeric Ui Conjugated to Indium-ill-and Yttrium.90-DOTA-Peptide in Tumor-Bearing Mice

G. Denardo, S. Denardo, Min Li, 2006 .

Development of a Radiolabeled Irreversible Peptide Ligand for PET Imaging of Vascular Endothelial Growth Factor

C. Meares, J. Parry, B. Rogers, 2014, The Journal of Nuclear Medicine.

The Peptide Way to Macrocyclic Bifunctional Chelating Agents: Synthesis of 2‐(p‐Nitrobenzyl)‐1,4,7,10‐tetraazacyclododecane‐N,N′,N′′,N′′′‐tetraacetic Acid (VI) and Study of Its Yttrium(III) Complex.

S. Denardo, C. Meares, M. Moi, 1988 .

Mapping the Path of a Growing Ribonucleic Acid Molecule

C. Meares, 1991 .

Quantitative photoaffinity labeling of Escherichia coli RNA polymerase transcription complexes by nascent RNA

T. Stackhouse, C. Meares, 1989 .

Photoaffinity labeling of Escherichia coli RNA polymerase/poly[d(A-T)] transcription complexes by nascent RNA.

T. Stackhouse, C. Meares, 1988, Biochemistry.

Synthesis of a cleavable dinucleotide photoaffinity probe of ribonucleic acid polymerase: application to trinucleotide labeling of an Escherichia coli transcription complex.

C. Meares, M. Hanna, 1983, Biochemistry.

Early steps in the path of nascent ribonucleic acid across the surface of ribonucleic acid polymerase, determined by photoaffinity labeling.

C. Meares, L. DeRiemer, 1981, Biochemistry.

Topography of transcription: path of the leading end of nascent RNA through the Escherichia coli transcription complex.

C. Meares, M. Hanna, 1983, Proceedings of the National Academy of Sciences of the United States of America.

Efficient multigram synthesis of the bifunctional chelating agent (S)-1-p-isothiocyanatobenzyl-diethylenetriaminepentaacetic acid [correction of diethylenetetraminepentaacetic acid].

C. Meares, D. Corson, 2000, Bioconjugate chemistry.

Biological properties of molecules labeled with metal ions using bifunctional chelates

J. Bushberg, C. Meares, D. Goodwin, 1977 .

Conjugation of antibodies with bifunctional chelating agents: isothiocyanate and bromoacetamide reagents, methods of analysis, and subsequent addition of metal ions.

C. Meares, M. Mccall, D. Goodwin, 1984, Analytical Biochemistry.

LYMPHOSCINTIGRAPHY WITH IN‐111 LABELED MONOCLONAL ANTIBODIES: A4

H. Mcdevitt, C. Meares, M. Mccall, 1983 .

Pilot therapy trial of CEA positive tumours using a three-step pretargeting approach

F. Fazio, F. Mangili, A. Siccardi, 1998 .

Pretargeting: general principles; October 10-12, 1996.

C. Meares, D. Goodwin, 1997, Cancer.

Therapy Trials in Cancer Patients Using an Improved 3-Step Pretargeting Approach

A. Corti, A. Siccardi, C. Meares, 1997 .

METABOLIZABLE IN‐111 CHELATE CONJUGATED ANTI‐IDIOTYPE MONOCLONAL ANTIBODY FOR RADIOIMMUNODETECTION OF LYMPHOMA IN MICE

M. Kaminski, T. Wensel, C. Meares, 1984 .

Evaluation of catheter thrombogenicity in vivo with indium-labeled platelets.

M. Lipton, P. Doherty, C. Meares, 1980, Radiology.

Diffusion-enhanced lanthanide energy-transfer study of DNA-bound cobalt(III) bleomycins: comparisons of accessibility and electrostatic potential with DNA complexes of ethidium and acridine orange.

C. Chang, T. Wensel, C. Meares, 1985, Biochemistry.

Exchange interaction contribution to energy transfer between ions in the rapid-diffusion limit

L. Stryer, C. Meares, S. Yeh, 1981 .

Targeted protein footprinting: where different transcription factors bind to RNA polymerase.

A. Ishihama, D. Yan, C. Meares, 1999, Biochemistry.

Metal chelates as probes of biological systems

T. Wensel, C. Meares, 1984 .

Peptide–Metal InteractionsBased in part on the article Peptide–Metal Interactions by Justin K. Moran & Claude F. Meares which appeared in the Encyclopedia of Inorganic Chemistry, First Edition.

C. Meares, 2011 .

Distance between metal-binding sites in transferrin: energy transfer from bound terbium (III) to iron (III) or manganese (III).

C. Meares, R. Bersohn, P. O’Hara, 1981, Biochemistry.

Characterization of transferrin metal-binding sites by diffusion-enhanced energy transfer.

C. Meares, S. Yeh, 1980, Biochemistry.

A new route to "bifunctional" chelating agents: conversion of amino acids to analogs of ethylenedinitrilotetraacetic acid.

C. Meares, D. Sherman, S. Yeh, 1979, Analytical biochemistry.

Specific cleavage of a protein by an attached iron chelate

T. Rana, C. Meares, Claude F. Meares, 1990 .

Rates and equilibria for probe capture by an antibody with infinite affinity.

A. Wu, W. Weber, T. Aweda, 2010, Bioconjugate chemistry.

Identification of a key structural feature of cobalt(III)-bleomycins: an exogenous ligand (e.g. hydroperoxide) bound to cobalt.

C. Chang, C. Meares, J. Dallas, 1983, Biochemical and biophysical research communications.

Protein-protein interactions mapped by artificial proteases: where sigma factors bind to RNA polymerase.

C. Meares, S. Datwyler, 2000, Trends in biochemical sciences.

Restructuring of an RNA polymerase holoenzyme elongation complex by lambdoid phage Q proteins

Jeffrey W. Roberts, M. Marr, C. Meares, 2001, Proceedings of the National Academy of Sciences of the United States of America.

Principles and methods of affinity cleavage in studying transcription.

A. Ishihama, C. Meares, J. Owens, 2003, Methods in enzymology.

Transfer of oxygen from an artificial protease to peptide carbon during proteolysis.

T. Rana, C. Meares, T M Rana, 1991, Proceedings of the National Academy of Sciences of the United States of America.

Helix packing in the lactose permease of Escherichia coli: distances between site-directed nitroxides and a lanthanide.

W. Hubbell, H. Kaback, J. Wu, 2001, Biochemistry.

Metallic Radionuclides for Radioimmunotherapy

C. Meares, A. Fritzberg, 2000 .

Footprint of the sigma protein.

C. Meares, U. Ramesh, 1989, Biochemical and biophysical research communications.

The interaction of anions with native and phenylglyoxal-modified human serum transferrin.

M. Penner, C. Meares, R. Feeney, 1987, Archives of biochemistry and biophysics.

BLEDTA: tumor localization by a bleomycin analogue containing a metal-chelating group.

C. Meares, D. Goodwin, C. Diamanti, 1979, Journal of medicinal chemistry.

The two alpha subunits of Escherichia coli RNA polymerase are asymmetrically arranged and contact different halves of the DNA upstream element.

M. Kimura, K. Murakami, A. Ishihama, 1997, Proceedings of the National Academy of Sciences of the United States of America.

RNA contacts subunits IIo and IIc in HeLa RNA polymerase II transcription complexes.

C. Meares, B. Bartholomew, M. Dahmus, 1986, The Journal of biological chemistry.

Synergy of Taxol and radioimmunotherapy with yttrium-90-labeled chimeric L6 antibody: efficacy and toxicity in breast cancer xenografts.

K. Lamborn, G. Denardo, S. Denardo, 1997, Proceedings of the National Academy of Sciences of the United States of America.

High-Dose Radioimmunotherapy Combined with Fixed, Low-Dose Paclitaxel in Metastatic Prostate and Breast Cancer by Using a MUC-1 Monoclonal Antibody, m170, Linked to Indium-111/Yttrium-90 via a Cathepsin Cleavable Linker with Cyclosporine to Prevent Human Anti-mouse Antibody

K. Lamborn, G. Denardo, S. Denardo, 2005, Clinical Cancer Research.

Are radiometal-labeled antibodies better than iodine-131-labeled antibodies: comparative pharmacokinetics and dosimetry of copper-67-, iodine-131-, and yttrium-90-labeled Lym-1 antibody in patients with non-Hodgkin's lymphoma.

G. Denardo, S. Denardo, S. Shen, 2000, Clinical lymphoma.

Positioning of σS, the stationary phase σ factor, in Escherichia coli RNA polymerase–promoter open complexes

F. Colland, N. Fujita, A. Ishihama, 1999 .

Energy transfer between terbium and iron bound to transferrin: reinvestigation of the distance between metal-binding sites.

C. Meares, J. E. Ledbetter, 1977, Biochemistry.

Diffusion-enhanced fluorescence energy transfer.

L. Stryer, D. D. Thomas, C. Meares, 1982, Annual review of biophysics and bioengineering.

The sigma subunit of RNA polymerase contacts the leading ends of transcripts 9-13 bases long on the lambda PR promoter but not on T7 A1.

C. Meares, S. L. Bernhard, 1986, Biochemistry.

Accessibility of the leading end of ribonucleic acid in transcription complexes.

C. Meares, S. L. Bernhard, 1986, Biochemistry.

Comparison of 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid (DOTA)-peptide-ChL6, a novel immunoconjugate with catabolizable linker, to 2-iminothiolane-2-[p-(bromoacetamido)benzyl]-DOTA-ChL6 in breast cancer xenografts.

K. Lamborn, G. Denardo, S. Denardo, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

Copper-67-Labeled Monoclonal Antibody Lym- 1, A Potential Radiopharmaceutical for CancerTherapy:Labelingand Biodistribution in RAJI Tumored Mice

G. Denardo, S. Denardo, G. Adams, 2022 .

Antibodies with infinite affinity

C. Meares, A. Chmura, C F Meares, 2001, Proceedings of the National Academy of Sciences of the United States of America.

Efficacy and toxicity of 67Cu-2IT-BAT-Lym-1 radioimmunoconjugate in mice implanted with human Burkitt's lymphoma (Raji).

G. Denardo, S. Denardo, S. Shen, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

Stable bifunctional chelates of metals used in radiotherapy.

S. Denardo, C. Meares, M. Moi, 1990, Cancer research.

Bifunctional chelating agents for radiometal-labeled monoclonal antibodies.

C. Meares, R. Subramanian, 1990, Cancer treatment and research.

Use of Bifunctional Chelating Agents for Radiolabeling Antibodies

C. Meares, 1986 .

Release of the sigma subunit from Escherichia coli RNA polymerase transcription complexes is dependent on the promoter sequence.

A. Telesnitsky, T. Stackhouse, C. Meares, 1989, Biochemistry.

Organization of open complexes at Escherichia coli promoters. Location of promoter DNA sites close to region 2.5 of the sigma70 subunit of RNA polymerase.

N. Fujita, S. Busby, S. Minchin, 1999, Journal of Biological Chemistry.

Mapping the promoter DNA sites proximal to conserved regions of sigma 70 in an Escherichia coli RNA polymerase-lacUV5 open promoter complex.

K. Murakami, N. Fujita, A. Ishihama, 1998, Biochemistry.

Method to site-specifically identify and quantitate carbonyl end products of protein oxidation using oxidation-dependent element coded affinity tags (O-ECAT) and nanoliquid chromatography Fourier transform mass spectrometry.

C. Lebrilla, C. Meares, N. L. Young, 2006, Journal of proteome research.

Liposomal Cu-64 labeling method using bifunctional chelators: poly(ethylene glycol) spacer and chelator effects.

J. Seo, L. Mahakian, K. Ferrara, 2010, Bioconjugate chemistry.

Iron chelate mediated proteolysis: Protein structure dependence

T. Rana, C. Meares, 1991 .

RadioimmunoPET: detection of colorectal carcinoma with positron-emitting copper-64-labeled monoclonal antibody.

M J Welch, F Dehdashti, P. Cutler, 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Irreversibly binding anti-metal chelate antibodies: Artificial receptors for pretargeting.

C. Meares, P. Whetstone, T. M. Corneillie, 2006, Journal of inorganic biochemistry.

Ring strain effects. IV. An electron spin resonance study of the radical anions of a series of strained naphthalene hydrocarbons

R. Rieke, C. Meares, S. E. Bales, 1974 .

RING STRAIN EFFECTS PART 4, AN ELECTRON SPIN RESONANCE STUDY OF THE RADICAL ANIONS OF A SERIES OF STRAINED NAPHTHALINE HYDROCARBONS

R. Rieke, C. Meares, S. E. Bales, 1974 .

The study of biological macromolecules using perturbed angular correlations of gamma radiation.

C. Meares, D. Westmoreland, 1972, Cold Spring Harbor symposia on quantitative biology.

Benzocyclobutene radical anion

R. Rieke, C. Meares, S. E. Bales, 1970 .

Copper-64-labeled antibodies for PET imaging.

M J Welch, M. Welch, C. Meares, 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Electrostatic properties of myoglobin probed by diffusion-enhanced energy transfer

T. Wensel, C. Meares, 1983 .

Exchange interaction contribution to energy transfer between ions in the rapid-diffusion limit

L. Stryer, C. Meares, S. Yeh, 1981 .

The pharmacokinetics of Zr-89 labeled liposomes over extended periods in a murine tumor model.

J. Seo, L. Mahakian, K. Ferrara, 2015, Nuclear medicine and biology.

Comparative oxidations of tyrosines and methionines in transferrins: human serum transferrin, human lactotransferrin, and chicken ovotransferrin.

M. Penner, R. Yamasaki, C. Meares, 1983, Archives of biochemistry and biophysics.

Interaction of anions with iron-transferrin-chelate complexes.

C. Meares, T. Rogers, R. Feeney, 1977, The Journal of biological chemistry.

Physical and chemical properties of radionuclide therapy.

B. Wessels, C. Meares, 2000, Seminars in radiation oncology.

Metal decomposition rates of 111In‐DPTA and EDTA conjugates of monoclonal antibodies in vivo

C. Meares, M. Mccall, D. Goodwin, 1986, Nuclear medicine communications.

Synthesis of the protein cutting reagent iron (S)-1-(p-bromoacetamidobenzyl)ethylenediaminetetraacetate and conjugation to cysteine side chains.

A. Ishihama, C. Meares, A. D. Jones, 1997, Bioconjugate chemistry.

Phosphorylation-Induced Signal Propagation in the Response Regulator NtrC

S. Kustu, C. Meares, J. Owens, 2000, Journal of bacteriology.

Site-Directed Photocleavage for Mapping Protein Architecture

W. Jackson, C. Meares, J. Owens, 1999 .

Positioning of Region 4 of the Escherichia coli RNA Polymerase ς70 Subunit by a Transcription Activator

A. Ishihama, S. Busby, A. Kolb, 2000, Journal of bacteriology.

Editorial - What's New for 1995

C. Meares, 1995 .

RADIOCHEMISTRY AIMD RADIOPHARMACEUTICALS lndium-111-Labeled Autologous Platelets for Location of Vascular Thrombi in Humans

M. Lipton, J. Bushberg, P. Doherty, 2008 .

Proteolytic DNA for mapping protein-DNA interactions.

C. Meares, B. Schmidt, 2002, Biochemistry.

Mapping protein-protein interactions with a library of tethered cutting reagents: the binding site of sigma 70 on Escherichia coli RNA polymerase.

C. Meares, S. Datwyler, S. Traviglia, 1999, Biochemistry.

Mapping protein-protein interactions by localized oxidation: consequences of the reach of hydroxyl radical.

C. Meares, S. Cheal, Z. Miao, 2009, Biochemistry.

Antibodies against metal chelates

C. Meares, M. Stone, R. Bartholomew, 1985, Nature.

Proximity mapping the surface of a membrane protein using an artificial protease: demonstration that the quinone-binding domain of subunit I is near the N-terminal region of subunit II of cytochrome bd.

R. Gennis, C. Meares, D. P. Greiner, 1995, Biochemistry.

Sequences of the Lym-1 antibody heavy and light chain variable regions.

C. Meares, A. Wellman, 1990, Nucleic acids research.

Improved Synthesis of 6‐(p‐(Bromoacetamido)benzyl)‐1,4,8,11‐ tetraazacyclotetradecane‐N,N′,N′′,N′′′‐tetraacetic Acid (I) and Development of a Thin‐Layer Assay for Thiol‐Reactive Bifunctional Chelating Agents.

C. Meares, D. P. Greiner, J. Moran, 1995 .

Subunit contacts of the rifamycin binding site of RNA polymerase (B. subtilis).

L. S. Rice, C. Meares, 1978, Biochemical and Biophysical Research Communications - BBRC.

Effects of sigma subunit and DNA template on the accessibility of rifamycin bound to RNA polymerase.

L. S. Rice, C. Meares, 1982, Biochemical and biophysical research communications.

Diffusion-enhanced energy transfer shows accessibility of ribonucleic acid polymerase inhibitor binding sites.

L. S. Rice, C. Meares, 1981, Biochemistry.

Footprint of the sigma protein: a re-examination.

C. Meares, A. Wellman, 1991, Biochemical and biophysical research communications.

Lymphoma-selective antibody Lym-1 recognizes a discontinuous epitope on the light chain of HLA-DR10

A. Gunasekera, G. Denardo, S. Denardo, 1996, Cancer Immunology, Immunotherapy.